0000899243-22-020145.txt : 20220531 0000899243-22-020145.hdr.sgml : 20220531 20220531160511 ACCESSION NUMBER: 0000899243-22-020145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220526 FILED AS OF DATE: 20220531 DATE AS OF CHANGE: 20220531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDonald Andrew I CENTRAL INDEX KEY: 0001734292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39244 FILM NUMBER: 22983179 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET STREET 2: FLOOR 16 CITY: NEW YORK STATE: NY ZIP: 10004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vincerx Pharma, Inc. CENTRAL INDEX KEY: 0001796129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 833197402 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-800-6676 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Vincera Pharma, Inc. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: LifeSci Acquisition Corp. DATE OF NAME CHANGE: 20191206 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-26 0 0001796129 Vincerx Pharma, Inc. VINC 0001734292 McDonald Andrew I 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306 1 0 1 0 Stock Option (right to buy) 1.61 2022-05-26 4 A 0 15000 0.00 A 2032-05-25 Common Stock 15000 15000 D The option vests in full on the earlier of May 26, 2023, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service. By: /s/ Andrew I. McDonald 2022-05-31